These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6192640)

  • 1. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H; Mustakallio KK
    Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritation and staining by dithranol (anthralin) and related compounds: I. Estimation with chamber testing and contact thermography.
    Mustakallio KK
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):125-32. PubMed ID: 294088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritation and staining by dithranol (anthralin) and related compounds. IV. Visual estimation of erythema compared with contact thermometry and laser Doppler flowmetry.
    Mustakallio KK; Kolari PJ
    Acta Derm Venereol; 1983; 63(6):513-8. PubMed ID: 6198841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
    Mustakallio KK
    Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice.
    Männistö PT; Vaissi L; Mustakallio KK; Viluksela M; Kosma VM; Collan Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):255-60. PubMed ID: 6423812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
    Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppression of dithranol erythema by the addition of tar in short-term therapy].
    Wozel G; Barth J
    Dermatol Monatsschr; 1985; 171(12):818-9. PubMed ID: 4092792
    [No Abstract]   [Full Text] [Related]  

  • 13. Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
    Greaves MW
    Int J Clin Pharmacol Res; 1986; 6(4):315-6. PubMed ID: 2428761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
    Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
    Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transepidermal water vapour loss is not increased during and following dithranol irritation.
    Snater E; Janssen EA; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 1995 Jun; 132(6):908-12. PubMed ID: 7662568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin susceptibility to dithranol: contact allergy or irritation?
    Loffler H; Effendy I; Happle R
    Eur J Dermatol; 1999; 9(1):32-4. PubMed ID: 9920984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
    Parslew R; Friedmann PS
    Br J Dermatol; 1999 Sep; 141(3):469-74. PubMed ID: 10583050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential factors influencing dithranol erythema].
    Richter G; Barth J
    Dermatol Monatsschr; 1986; 172(5):272-5. PubMed ID: 3721033
    [No Abstract]   [Full Text] [Related]  

  • 19. [Side effects of anthralin and its 2 main impurities on healthy skin].
    Puschmann M; Schmersahl P
    Z Hautkr; 1983 Mar; 58(6):410-6. PubMed ID: 6857758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.